• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Crohn’s Disease
Tags
  • Crohn’s Disease
Study title Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease
Disease or condition Active, moderate to severe Crohn’s disease
Study type Interventional (Clinical Trial)
Intervention/treatment Etrasimod vs Placebo (open label extension possible)
Phase 2b
Study site Duke University
Study location Durham
Principal investigator Jane Onken
Study coordinator Christy Walters, christy.walters@duke.edu
Phone contact 919-688-5499
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT04173273

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE